BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1774355)

  • 21. Distinctive acral erythema occurring during therapy for severe myelogenous leukemia.
    Levine LE; Medenica MM; Lorincz AL; Soltani K; Raab B; Ma A
    Arch Dermatol; 1985 Jan; 121(1):102-4. PubMed ID: 3855356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciliated and Mucinous Adenomatous Syringometaplasia: The Missing Link of the "Ciliated Eccrine Metaplasia" Theory in the Histogenesis of Cutaneous Eccrine Ciliated Cyst?
    Tran TAN
    Am J Dermatopathol; 2021 Nov; 43(11):827-830. PubMed ID: 33606368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy-induced acral erythema: report of a case and immunohistochemical findings.
    Tsuruta D; Mochida K; Hamada T; Ishii M; Wakasa K; Hashimoto S; Takekawa KE
    Clin Exp Dermatol; 2000 Jul; 25(5):386-8. PubMed ID: 11012591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eccrine squamous syringometaplasia secondary to cutaneous extravasation of docetaxel: report of three cases.
    Gallo E; Llamas-Velasco M; Navarro R; Fraga J; GarcĂ­a-Diez A
    J Cutan Pathol; 2013 Mar; 40(3):326-9. PubMed ID: 23170995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syringometaplasia: mucinous and squamous variants.
    King DT; Barr RJ
    J Cutan Pathol; 1979 Aug; 6(4):284-91. PubMed ID: 500875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis'.
    Hurt MA; Halvorson RD; Petr FC; Cooper JT; Friedman DJ
    Arch Dermatol; 1990 Jan; 126(1):73-7. PubMed ID: 2404465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
    Story SG; Beschloss JK; Dolan CK; Thomas BC
    J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
    [No Abstract]   [Full Text] [Related]  

  • 28. Vemurafenib-induced eccrine squamous syringometaplasia.
    Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
    Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine-induced eccrine squamous syringometaplasia.
    Molina-Ruiz AM; Molina-Ruiz RM; Zulueta T; Barabash R; Requena L
    Am J Dermatopathol; 2012 Jun; 34(4):434-7. PubMed ID: 22257902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acral erythema after allogeneic graft of the bone marrow].
    Dechaufour F; Dompmartin A; Troussard X; Galateau F; Pedailles S; Remond B; Leporrier M; Leroy D
    Ann Dermatol Venereol; 1993; 120(3):219-22. PubMed ID: 8239360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syringometaplasia: variants and underlying mechanisms.
    Abbas O; Bhawan J
    Int J Dermatol; 2016 Feb; 55(2):142-8. PubMed ID: 26460811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel.
    Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A
    J Dermatol; 2015 Nov; 42(11):1134-5. PubMed ID: 26299585
    [No Abstract]   [Full Text] [Related]  

  • 33. Eccrine squamous syringometaplasia and syringomatous hyperplasia in association with linear scleroderma.
    Sakai H; Satoh K; Manabe A; Nakane H; Ishida-Yamamoto A; Iizuka H
    Dermatology; 2002; 204(2):136-8. PubMed ID: 11937740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A papulovesicular eruption in a man receiving chemotherapy for metastatic melanoma. Squamous syringometaplasia (squamous metaplasia) of the eccrine glands.
    Wong P; Bangert JL; Levine N
    Arch Dermatol; 1993 Feb; 129(2):232-3, 235-6. PubMed ID: 8434984
    [No Abstract]   [Full Text] [Related]  

  • 35. Eccrine squamous syringometaplasia. A prospective clinicopathologic study.
    Serrano T; Saez A; Moreno A
    J Cutan Pathol; 1993 Feb; 20(1):61-5. PubMed ID: 7682228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet.
    Kroll SS; Koller CA; Kaled S; Dreizen S
    Ann Plast Surg; 1989 Sep; 23(3):263-5. PubMed ID: 2528937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eccrine squamous syringometaplasia from chemotherapy extravasation].
    Bordel MT; Miranda A
    Actas Dermosifiliogr; 2005 Sep; 96(7):462-4. PubMed ID: 16476276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acral erythema: a clinical review.
    Cohen PR
    Cutis; 1993 Mar; 51(3):175-9. PubMed ID: 8444048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syringosquamous metaplasia. A distinctive eruption in patients receiving chemotherapy.
    Bhawan J; Malhotra R
    Am J Dermatopathol; 1990 Feb; 12(1):1-6. PubMed ID: 2316809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bullous variant of chemotherapy-induced acral erythema.
    Waltzer JF; Flowers FP
    Arch Dermatol; 1993 Jan; 129(1):43-5. PubMed ID: 8420487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.